Get ready for groundbreaking innovation in healthcare solutions.

We’re developing advanced therapies to address chronic liver diseases like NAFLD and NASH like:

Revolutionary Therapies: Cutting-edge peptidomimetic treatments targeting liver inflammation, fibrosis, and metabolism.

Innovative Research: Leveraging SOCS1-derived peptides for safer, more effective therapeutic solutions.

Commitment to Patients: Solutions designed to improve quality of life for those with diabetes, obesity, and liver conditions.

Web site available soon

Biomedic Startup